ConductScience.org, home

Comparison · NCT01720667-8370d3dd

Intravenous Levetiracetam vs Intravenous Phenobarbital: Neonates With Seizure Cessation When Given Levetiracetam as First Line Therapy Compared to Phenobarbital Within the Hypoxic Ischemic Encephalopathy (HIE) Population and Treated With Hypothermia

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Intravenous Levetiracetam vs Intravenous Phenobarbital: Neonates With Seizure Cessation When Given Levetiracetam as First Line Therapy Compared to Phenobarbital Within the Hypoxic Ischemic Encephalopathy (HIE) Population and Treated With Hypothermia. Trial comparisons, record NCT01720667-8370d3dd. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT01720667-8370d3dd

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.3530.1730.587wilson
Risk in group 20.90.5960.982wilson
Risk difference, group 1 minus group 2-0.547-0.745-0.163newcombe hybrid score
Risk ratio, group 1 over group 20.3920.1990.771log
Odds ratio, group 1 over group 20.06060.006120.6log
Number needed to treat, for one fewer participant with the outcome on Intravenous Levetiracetam than on Intravenous Phenobarbital1.831.346.12from the risk difference interval

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Intravenous LevetiracetamIntravenous levetiracetam 40 - 60 mg/kg loading dose \& 10 mg/kg 8 hourly maintenance617OG000
Group 2Intravenous PhenobarbitalIntravenous phenobarbital 20 - 40 mg/kg loading dose \& 1.5 mg/kg 8 hourly maintenance.910OG001

Outcome

Type
SECONDARY
Title
Neonates With Seizure Cessation When Given Levetiracetam as First Line Therapy Compared to Phenobarbital Within the Hypoxic Ischemic Encephalopathy (HIE) Population and Treated With Hypothermia
Description
Time frame
24 hours
Population
HIE participants with hypothermia treatment

Source ClinicalTrials.gov

Trial

Title
Efficacy of Intravenous Levetiracetam in Neonatal Seizures
NCT number
NCT01720667
Phases
PHASE1, PHASE2
Conditions
Neonatal Seizures
Interventions
Intravenous levetiracetam, Intravenous phenobarbital
Lead sponsor
Richard H. Haas
Results first posted
2019-08-21

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT01720667-8370d3dd